About

Stefan Verheyden was Global Vice-President, Gx Biological Solutions at Gerresheimer until October 2025, when he moved to Sanner.

He started his career in product management in the lab chemicals industry, before moving into leading sales and business development roles in production chemistry, raw materials and APIs at two major companies. After 20 years Mr Verheyden moved into the pharma packaging industry, taking over a global role as Senior Vice-President at one of the players within the industry. He moved to Gerresheimer in 2017, heading both the syringe business as well as a new business unit supporting the fast-growing biological market segment. Mr Verheyden studied chemistry at the University of Brussels (Belgium).

Contributions

PREFILLED SYRINGES

GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES

Wenzel Novak and Stefan Verheyden introduce Gx InnoSafe, a novel integrated passive needle safety system for preventing needlestick injuries and accidental reuse of syringes that minimises additional burden on healthcare workers during injection and can be integrated into existing pharmaceutical filling operations without the need for adaptation or conversion of processing lines.